SCHEMBL6537162

SCHEMBL6537162

CC(O)CCCCCCC=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
ALDH1A1 P00352 3/20 0.50
TSHR P16473 2/20 0.48
TRPV1 Q8NER1 4/20 0.43
FAAH O00519 2/20 0.43
HIF1A Q16665 1/20 0.41
TRPA1 O75762 2/20 0.36
CYP3A4 P08684 2/20 0.35
USP2 O75604 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2C9 P11712 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.34
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH4 P08319 1/20 0.33
ADH7 P40394 1/20 0.33
DDAH1 O94760 1/20 0.32
GAPDH P04406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4937612 1.00 MAPT (0.50) MAPTALDH1A1TSHRTRPV1FAAH
SCHEMBL7147272 1.00 MAPT (0.50) MAPTALDH1A1TSHRTRPV1FAAH
Nonanal SCHEMBL11055718 0.92 TSHR (0.64) MAPTALDH1A1TSHRTRPV1FAAH
SCHEMBL457172 0.90
SCHEMBL746873 0.90
SCHEMBL749955 0.85
SCHEMBL17316227 0.85
SCHEMBL28569086 0.82
SCHEMBL11902617 0.82 TSHR (0.44) MAPTALDH1A1TSHRTRPV1FAAH
SCHEMBL15327039 0.80 TSHR (0.52) MAPTALDH1A1TSHRTRPV1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4530281-A1 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-04-02 EP disclosed
US-20250084028-A1 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-03-13 US disclosed
CN-119569571-A 8- (Acyloxy) alkanal compound, process for producing the same, and process for producing 2, 9-diacetoxy undecane from the 8- (acyloxy) alkanal compound 信越化学工业株式会社 2025-03-07 CN disclosed
US-20040233377-A1 Liquid crystal display device COGNOA, INC. 2004-11-25 US disclosed
US-6757044-B2 Liquid crystal display device with spacers controlling thickness of liquid crystal layer HITACHI, LTD. (JP) 2004-06-29 US disclosed
US-20030002005-A1 Liquid crystal display device with spacers controlling thickness of liquid crystal layer IPS ALPHA SUPPORT CO., LTD. (JP) 2003-01-02 US disclosed
US-6441880-B1 Normally closed liquid crystal display device using spacers coated with material having liquid crystal aligning ability by irradiation with polarized light HITACHI, LTD. (JP) 2002-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084028-A1 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND CUL1, UBA1, UBE2E1 MAPT 3762/4885ALDH1A1 185/4885TSHR 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.